Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-617-1 | CAS number: 674-82-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
NOEL (single implantation, female rat): 1.1 mg/rat (highest dose tested; basic data only)
NOEL (s.c., once weekly, 20 months, mouse): 1.1 mg/application (highest dose tested)
NOEL (s.c., once weekly, lifespan, female rat): 4 mg/application (highest dose tested)
NOEL (dermal, three times weekly, lifespan, mouse): 122.5 mg/kg bw/d (highest dose tested)
Key value for chemical safety assessment
Justification for classification or non-classification
Diketene does not have to be classified for carcinogenicity according to the criteria laid down in the EU Dangerous Substances Directive (67/548/EEC) and in the EU Classification Labelling and Packaging Regulation (1272/2008/EC) because in several carcinogenicity studies performed with rats and mice it did not show any carcinogenic effect.
Additional information
Several carcinogenicity studies were performed with Diketene:
- Subcutaneous implantation of Gelatine capsules containing 1.1 mg Diketene in 10 mg of Trilaurin-tricaprylin (4:1) were made in the left axillary region in rats. No tumors were observed 20 months after application.Diketene is inactive as a carcinogen in spite of its high chemical activity with nucleophilic and electrophilic reagents such as alcohols, aldehydes, amines, and ketones. This compound, which can be thought of as the anhydride of acetoacetic acid, hydrolyzes in water to this acid. In the presence of catalysts, this hydrolysis is rapid. This factor, combined with its chemical reactivity, may preclude its reaction at in vivo sites important for carcinogenesis. The hydrolysis rate constant for Diketene at 37 °C is given as 120 [min EE -1 X 10 EE 3].
- Subcutaneous injection of Diketene in mice with tricaprylin as vehicle, once weekly. 1.1 mg per injection. No tumors were observed after 20 months.
- Subcutaneous injection in female Sprague-Dawley rats.4 mg Diketene in 0.1 ml tricaprylin was subcutaneously injected once weekly in the left axillary area. The rats were examined regularly for palpable masses and their condition was recorded once a month. They were treated and observed for their lifspans (543 days). No local subcutaneous sarcomas were found.
.
- The backs of female ICR/Ha Swiss mice were freed of hair and applications of close to 100 mg of 10% solutions were made 3 times weekly onto the dorsal skin. Mice were individually weighed and observed regularly and their tumors were charted on appearance. At the time of death all animals were autopsied. All abnormal tissues and tumors were investigated microscopically. Diketene did not cause carcinogenic effects in this study. The lack of effect was so far seen on the rapid hydrolisis of the Diketene. The application of Diketene in Tricaprylin, in which hydrolisis presumably is slower, yielded however also no carcinogenic effects.
- Male Swiss-Millerton mice were painted 3 times weekly with approx. 100 mg of a 10% Diketene in Acetone solution per application. The entire backs of the animals were painted and the hair clipped when necessary. 4 control groups with 3 times weekly painting of Benzene, Acetone, Benzo[a]pyrene, and no treatment were included . All tumors were excised at death and confirmed microscopically. The median survival time was 561 days. No tumors were observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.